Aqueous Extracts of Anogeissus Leiocarpus (DC.) Guill. & Perr. and Terminalia Glaucescens Planch ex Benth. Inhibited Helicobacter Pylori

The inhibitory effects of methanol, dichloromethane and aqueous extracts of Anogeissus leiocarpus (DC.) Guill. & Perr. and Terminalia glaucescens Planch ex Benth. (family Combretaceae) reportedly used in the treatment of gastrointestinal diseases including stomach disorder and ulcer are investigated to ascertain and justify their use in traditional medicine. Nineteen (19) strains of Helicobacter pylori including 18 clinical isolates and Helicobacter pylori ATCC 43504 were used in this study. The susceptibility and minimum inhibitory concentration (MIC) testing were performed using the agar dilution procedure guidelines of the Clinical and Laboratory Standards Institute. bactericidal studies were performed using viable counting techniques. The MIC and MBC values for the susceptible strains ranged from 0.08 mg/mL to 1.25 mg/mL and 0.16 mg/mL - 2.5 mg/mL respectively Bactericidal study revealed a dose- and time-dependent decline in surviving population of H. pylori AB005 at concentrations equivalent to MIC, 2 x MIC and 4 x MIC (Figures 1-4). The aqueous extracts of Anogeissus leiocarpus stem bark and root gave a 100% kill at 6-hour exposure time with concentration equivalent to 4x MIC (i.e. 0.32mg/mL). The antimicrobial activities demonstrated by extracts of the plants on Helicobacter pylori revealed the presence of therapeutically potent antibacterial compounds and thus justify the use of these medicinal plants for the treatment of peptic ulcer disease. Keywords: Anogeissus leiocarpus (DC.) Guill. & Perr.; Terminalia glaucescens Planch ex Benth.; Helicobacter pylori; peptic ulcer disease; bactericidal activit

Estrogenic effects of herbal medicines from Costa Rica used for the management of menopausal symptoms

Objective: Outcomes from the Women's Health Initiative have demonstrated adverse effects associated with hormone therapy and have prioritized the need to develop new alternative treatments for the management of menopause and osteoporosis. To this end, we have been investigating natural herbal medicines used by Costa Rican women to manage menopausal symptoms. Methods: Seventeen plant species were collected and extracted in Costa Rica. To establish possible mechanisms of action and to determine their potential future use for menopause or osteoporosis, we investigated the estrogenic activities of the herbal extracts in an estrogen-reporter gene estrogen receptor (ER) β-Chemically Activated Luciferase Expression assay in U2-OS cells and in reporter and endogenous gene assays in MCF-7 cells. Results: Six of the plant extracts bound to the ERs. Four of the six extracts stimulated reporter gene expression in the ER-β-Chemically Activated Luciferase Expression assay. All six extracts modulated expression of endogenous genes in MCF-7 cells, with four extracts acting as estrogen agonists and two extracts, Pimenta dioica and Smilax domingensis, acting as partial agonist/antagonists by enhancing estradiol-stimulated pS2 mRNA expression but reducing estradiol-stimulated PR and PTGES mRNA expression. Both P. dioica and S. domingensis induced a 2ERE-luciferase reporter gene in transient transfected MCF-7 cells, which was inhibited by the ER antagonist ICI 182,780. Conclusions: This work presents a plausible mechanism of action for many of the herbal medicines used by Costa Rican women to treat menopausal symptoms. However, it further suggests that studies of safety and efficacy are needed before these herbs should be used as alternative therapies to hormone therapy.UCR::Vicerrectoría de Investigación::Unidades de Investigación::Ciencias Básicas::Centro de Investigaciones en Productos Naturales (CIPRONA

Overview of Botanical Status in EU, USA, and Thailand

The botanical status in EU, USA, and Thailand is different owing to the regulatory status, the progress of science, and the influence of culture and society. In the EU, botanicals are positioned as herbal medicinal products and food supplements, in the US they are regulated as dietary supplements but often used as traditional medicines, and in Thailand, they are regulated and used as traditional medicines. Information for some of the most popular botanicals from each country is included in this review

Traditional Thai Medicines Inhibit Helicobacter pylori in vitro and in vivo: Support for Ethnomedical Use

In Thailand, traditional plant-based medicines have always been used to treat gastrointestinal ailments, including gastritis, peptic ulcer disease (PUD) and diarrhea. Since Helicobacter pylori (HP) is an etiological agent of PUD, we have used an ethnomedical approach for screening plant extracts as potential treatments for HP infections, including over 20 species from Thailand. International Memoranda of Agreement were established between UIC and Mahidol University in Thailand. Medicinal plants were collected, identified and extracted. Susceptibility testing was performed with 15 HP strains using the agar dilution procedure guidelines of the Clinical and Laboratory Standards Institute. In vivo studies included evaluating bacterial load, as well as acute and chronic inflammation in HP-infected Mongolian gerbils. Extracts of Curcuma longa L. and Boesenbergia rotunda (L.) Mansf. significantly reduced HP-induced gastric lesions, as assessed both macroscopically and microscopically in Mongolian gerbils. The treatments reduced acute and/or chronic inflammation in a prevention model of HP-induced gastritis

Astragalin, a Flavonoid from Morus alba (Mulberry) Increases Endogenous Estrogen and Progesterone by Inhibiting Ovarian Granulosa Cell Apoptosis in an Aged Rat Model of Menopause

Background: To determine the mechanism by which the flavonoid glycoside astragalin (AST) reduces ovarian failure in an aged rat model of menopause. Methods: The in vivo effect of AST on granulosa cell (GC) apoptosis in aged female rats was determined using flow cytometry. In vitro, the effects of AST on cultured GCs were investigated using the MTT proliferation assay and western blot assays. Results: Aged rats had significantly higher GC apoptosis as compared with young female rats. Treatment of aged rats with AST (all three doses; p < 0.01) or Progynova (p < 0.01) significantly reduced GC apoptosis as compared with the aged controls. The proportions of total apoptotic GCs was 25.70%, 86.65%, 47.04%, 27.02%, 42.09% and 56.42% in the normal, aged, 17β-estradiol (E2), high dose AST, medium dose AST, and low dose AST-treated groups, respectively. Significant increases of serum E2 and P4 levels, as well as altered levels of serum follicle stimulating hormone (FSH) and luteinizing hormone (LH) levels. In cultured rat GCs, AST stimulated GC proliferation, E2 and progesterone (P4) secretion, reduced apoptosis, reduced the level of the pro-apoptotic protein Bcl-2 (p < 0.01), but had no effect on BAX. Conclusions: AST enhanced ovarian function in aged female rats by increasing E2 and P4 levels, and reducing ovarian GC apoptosis via a mechanism involving Bcl-2. These data demonstrate a new pharmacological activity for AST, as well as a novel mechanism of action, and further suggest that AST may be a new therapeutic agent for the management of menopausal symptoms

Women's Health in Central America: The Complexity of Issues and the Need to Focus on Indigenous Healthcare

The Central American (CA) isthmus consists of seven countries including Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama, some of the poorest countries in the world. Over the past twenty years, CA has made good progress in improving the health status of their populations. Analysis of the peer-reviewed literature, as well as national and international reports show that life expectancy at birth has increased and child mortality rates have fallen. Maternal mortality ratios (MMR) have declined by approximately 33%, however the MMRs for indigenous women remain at unacceptable levels. Despite the advances, made in many CA countries, the overall health status remains well below Latin American averages. In fact, in most CA countries, poor health outcomes are increasingly concentrated geographically among the poor and indigenous populations. Considering indigenous people make up the second largest population group in CA, any improvements in healthcare should significantly improve the health statistics for these countries. For these populations, the integration of local cultural practices and traditional healing methods with modern medicine and healthcare facilities is critical for acceptance. Investigations and analyses of local cultures, knowledge and traditional medicine practices should be used to determine the factors that contribute to poor health in these populations. Local health educational programs are needed, especially those that would involve men (spouses), families and entire communities. Furthermore, manywomen’s reproductive issues still need to be addressed, particularly those that focus specifically on maternal mortality and cancer. For reductions in maternal mortality, El Salvador and Costa Rica may be good examples to follow. Access to inexpensive (or free) healthcare that is culturally sensitive and community based, particularly for indigenous women, would greatly improve the overall health. The major stumbling blocks to progress are that the funding for programs to reduce maternal mortality is woefully inadequate and that there has not been a focus on improving healthcare for indigenous women.Universidad de Costa RicaUCR::Vicerrectoría de Docencia::Ciencias Básicas::Facultad de Ciencias::Escuela de Químic